Chenyu Tian

2.2k total citations · 1 hit paper
24 papers, 1.4k citations indexed

About

Chenyu Tian is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Chenyu Tian has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in Chenyu Tian's work include Ferroptosis and cancer prognosis (3 papers), interferon and immune responses (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Chenyu Tian is often cited by papers focused on Ferroptosis and cancer prognosis (3 papers), interferon and immune responses (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Chenyu Tian collaborates with scholars based in China, Taiwan and United States. Chenyu Tian's co-authors include Shengyong Yang, Yueshan Li, Wei Yang, Lei Zhong, Zhuang Miao, Ming Wu, Tianqi Wang, Wenjing Wang, Liang Xiong and Ting Yuan and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and Computer Methods in Applied Mechanics and Engineering.

In The Last Decade

Chenyu Tian

23 papers receiving 1.4k citations

Hit Papers

Small molecules in targeted cancer therapy: advances, cha... 2021 2026 2022 2024 2021 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenyu Tian China 13 738 367 232 183 172 24 1.4k
Wenjing Wang China 15 927 1.3× 350 1.0× 247 1.1× 139 0.8× 146 0.8× 29 1.6k
Liang Xiong China 6 626 0.8× 307 0.8× 191 0.8× 127 0.7× 143 0.8× 10 1.1k
Yi Jer Tan China 13 694 0.9× 373 1.0× 198 0.9× 163 0.9× 260 1.5× 24 1.4k
Yeuan Ting Lee Malaysia 6 498 0.7× 300 0.8× 197 0.8× 139 0.8× 192 1.1× 9 1.0k
Aijun Shen China 23 1.0k 1.4× 353 1.0× 181 0.8× 129 0.7× 255 1.5× 39 1.6k
Sadaf Davudian Iran 6 1.0k 1.4× 419 1.1× 133 0.6× 139 0.8× 396 2.3× 8 1.7k
Dimitrios T. Trafalis Greece 20 957 1.3× 792 2.2× 300 1.3× 245 1.3× 303 1.8× 113 2.2k
Qingbin Cui China 22 1.0k 1.4× 679 1.9× 141 0.6× 185 1.0× 285 1.7× 49 1.8k
Kanami Yamazaki Japan 17 892 1.2× 334 0.9× 238 1.0× 130 0.7× 203 1.2× 27 1.4k
Pan Pantziarka Belgium 18 716 1.0× 397 1.1× 101 0.4× 161 0.9× 266 1.5× 47 1.5k

Countries citing papers authored by Chenyu Tian

Since Specialization
Citations

This map shows the geographic impact of Chenyu Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyu Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyu Tian more than expected).

Fields of papers citing papers by Chenyu Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenyu Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyu Tian. The network helps show where Chenyu Tian may publish in the future.

Co-authorship network of co-authors of Chenyu Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Chenyu Tian. A scholar is included among the top collaborators of Chenyu Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenyu Tian. Chenyu Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yunjie, et al.. (2024). Discovery of phenazine derivatives as a new class of non-classical ferroptosis inhibitors and efficacy evaluation on a mouse model of liver injury. European Journal of Medicinal Chemistry. 282. 117042–117042. 2 indexed citations
2.
Zhao, Lianhe, Chenyu Tian, Yueyue Li, et al.. (2024). Predicting transcriptional responses to novel chemical perturbations using deep generative model for drug discovery. Nature Communications. 15(1). 9256–9256. 18 indexed citations
3.
Huang, Chieh‐Sen, Todd Arbogast, & Chenyu Tian. (2023). Multidimensional WENO-AO Reconstructions Using a Simplified Smoothness Indicator and Applications to Conservation Laws. Journal of Scientific Computing. 97(1).
4.
Zhao, Junjie, Zhaoming Wang, Chenyu Tian, et al.. (2023). Single-cell RNA sequencing reveals the lineage of malignant epithelial cells and upregulation of TAGLN2 promotes peritoneal metastasis in gastric cancer. Clinical & Translational Oncology. 25(12). 3405–3419. 7 indexed citations
5.
Wu, Yingying, Junjie Zhao, Zhaoming Wang, et al.. (2023). Association of systemic inflammatory markers and tertiary lymphoid structure with pathological complete response in gastric cancer patients receiving preoperative treatment: a retrospective cohort study. International Journal of Surgery. 109(12). 4151–4161. 12 indexed citations
6.
Tian, Chenyu, et al.. (2023). Study of the Effect of Intestinal Microbes on Obesity: A Bibliometric Analysis. Nutrients. 15(14). 3255–3255. 7 indexed citations
7.
Zhao, Junjie, Jie Sun, Chenyu Tian, et al.. (2023). Intraoperative Pathological Evaluation of Suspicious Peritoneal Nodules for Surgical Decision-making in Gastric Cancer. Journal of Gastrointestinal Surgery. 27(8). 1545–1559. 1 indexed citations
8.
Zhang, Guo, Chenyu Tian, Anjie Xia, et al.. (2023). Discovery of 5-((1H-indazol-3-yl) methylene)-2-thioxoimidazolidin-4-one derivatives as a new class of AHR agonists with anti-psoriasis activity in a mouse model. Bioorganic & Medicinal Chemistry Letters. 92. 129383–129383. 5 indexed citations
9.
Zhang, Liting, Yueshan Li, Chenyu Tian, et al.. (2023). From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases. Journal of Medicinal Chemistry. 67(1). 754–773. 8 indexed citations
10.
Li, Yueshan, Yifei Wang, Jun Zou, et al.. (2022). Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor. Nature Communications. 13(1). 6891–6891. 55 indexed citations
11.
Yang, Wei, Bo Mu, Jing You, et al.. (2022). Non-classical ferroptosis inhibition by a small molecule targeting PHB2. Nature Communications. 13(1). 7473–7473. 41 indexed citations
12.
Jiang, Quan, Chenyu Tian, Hao Wu, et al.. (2022). Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer. Chinese Journal of Cancer Research. 34(3). 365–382. 30 indexed citations
13.
Tian, Chenyu, et al.. (2022). Identification of triazolopyridine derivatives as a new class of AhR agonists and evaluation of anti-psoriasis effect in a mouse model. European Journal of Medicinal Chemistry. 231. 114122–114122. 14 indexed citations
14.
Tian, Chenyu, Junjie Zhao, Dan Liu, et al.. (2022). Identification of metabolism-related genes for predicting peritoneal metastasis in patients with gastric cancer. BMC Genomic Data. 23(1). 84–84. 5 indexed citations
16.
Li, Yueshan, Liting Zhang, Ruicheng Yang, et al.. (2022). Discovery of 3,4-Dihydrobenzo[f][1,4]oxazepin-5(2H)-one Derivatives as a New Class of Selective TNIK Inhibitors and Evaluation of Their Anti-Colorectal Cancer Effects. Journal of Medicinal Chemistry. 65(3). 1786–1807. 17 indexed citations
17.
Li, Haojie, Junjie Zhao, Jie Sun, et al.. (2021). Demethylation of the SFRP4 Promoter Drives Gastric Cancer Progression via the Wnt Pathway. Molecular Cancer Research. 19(9). 1454–1464. 15 indexed citations
18.
Zhong, Lei, Yueshan Li, Liang Xiong, et al.. (2021). Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduction and Targeted Therapy. 6(1). 201–201. 1071 indexed citations breakdown →
19.
20.
Sun, Weining, Xiuli Chen, Shenzhen Huang, et al.. (2020). Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(16). 127215–127215. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026